These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18508372)

  • 1. Age, model for end-stage liver disease score, and organ functioning predict posttransplant tacrolimus neurotoxicity.
    DiMartini A; Fontes P; Dew MA; Lotrich FE; de Vera M
    Liver Transpl; 2008 Jun; 14(6):815-22. PubMed ID: 18508372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus Concentration/Dose Ratio is Associated with Renal Function After Liver Transplantation.
    Thölking G; Siats L; Fortmann C; Koch R; Hüsing A; Cicinnati VR; Gerth HU; Wolters HH; Anthoni C; Pavenstädt H; Suwelack B; Schmidt HH; Kabar I
    Ann Transplant; 2016 Mar; 21():167-79. PubMed ID: 27003330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus and mycophenolate mofetil after liver transplantation.
    Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Tscheliessnigg KH
    Transpl Int; 2003 Jul; 16(7):504-9. PubMed ID: 12687325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus.
    Jain A; DiMartini A; Kashyap R; Youk A; Rohal S; Fung J
    Transplantation; 2000 Nov; 70(9):1335-42. PubMed ID: 11087149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
    Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ
    Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection.
    Molmenti EP; Jain AB; Shapiro R; Scantlebury V; Lee R; Totsuka E; Flohr J; Rakela J; Fung JJ
    Transplantation; 2001 Jan; 71(2):267-71. PubMed ID: 11213072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation.
    Jain A; Mazariegos G; Kashyap R; Marsh W; Khanna A; Iurlano K; Fung J; Reyes J
    Pediatr Transplant; 2001 Apr; 5(2):93-8. PubMed ID: 11328546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients.
    Aguiar D; Martínez-Urbistondo D; Baroja-Mazo A; de la Mata M; Rodríguez-Perálvarez M; Rubín A; Puchades L; Serrano T; Montero J; Cuadrado A; Casafont F; Salcedo M; Rincón D; Pons JA; Herrero JI
    Ann Transplant; 2017 May; 22():265-275. PubMed ID: 28461684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
    Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
    Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postural hand tremor before and following liver transplantation and immunosuppression with cyclosporine or tacrolimus in patients without clinical signs of hepatic encephalopathy.
    Paul F; Müller J; Christe W; Steinmüller T; Poewe W; Wissel J
    Clin Transplant; 2004 Aug; 18(4):429-33. PubMed ID: 15233821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients.
    Cacciarelli TV; Reyes J; Jaffe R; Mazariegos GV; Jain A; Fung JJ; Green M
    Pediatr Transplant; 2001 Oct; 5(5):359-64. PubMed ID: 11560756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the incidence and clinical evolution of early neurotoxicity after liver transplantation based on tacrolimus formulation used in the immunosuppressive induction protocol.
    Souto-Rodríguez R; Molina-Pérez E; Castroagudín JF; Fernández Pérez A; Otero-Antón E; Tomé Martínez de Rituerto S; Martínez-Castro J; Varo-Pérez E
    Transplant Proc; 2014 Nov; 46(9):3117-20. PubMed ID: 25420839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated With Changes in Body Composition Shortly After Orthotopic Liver Transplantation: The Potential Influence of Immunosuppressive Agents.
    Brito-Costa A; Pereira-da-Silva L; Papoila AL; Alves M; Mateus É; Nolasco F; Barroso E
    Transplantation; 2016 Aug; 100(8):1714-22. PubMed ID: 27136260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Donor Age and Recipient Characteristics on Renal Outcomes in Patients Receiving Prolonged-Release Tacrolimus After Liver Transplantation: Post-Hoc Analyses of the DIAMOND Study.
    Trunečka P; Klempnauer J; Bechstein WO; Pirenne J; Bennet W; Zhao A; Isoniemi H; Rostaing L; Settmacher U; Mönch C; Brown M; Undre N; Kazeem G; Tisone G
    Ann Transplant; 2019 Jun; 24():319-327. PubMed ID: 31160549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients.
    Cuervas-Mons V; Herrero JI; Gomez MA; González-Pinto I; Serrano T; de la Mata M; Fabregat J; Gastaca M; Bilbao I; Varo E; Sánchez-Antolín G; Rodrigo J; Espinosa MD
    Clin Transplant; 2015 Aug; 29(8):667-77. PubMed ID: 25924549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial steroid-free immunosuppression after liver transplantation in recipients with hepatitis C virus related cirrhosis.
    Wietzke-Braun P; Braun F; Sattler B; Ramadori G; Ringe B
    World J Gastroenterol; 2004 Aug; 10(15):2213-7. PubMed ID: 15259068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor Age Predicts Calcineurin Inhibitor Induced Neurotoxicity After Liver Transplantation.
    Lué A; Martinez E; Navarro M; Laredo V; Lorente S; Jose Araiz J; Agustin Garcia-Gil F; Serrano MT
    Transplantation; 2019 Aug; 103(8):e211-e215. PubMed ID: 30985573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient.
    Kaczmarek I; Schmauss D; Sodian R; Beiras-Fernandez A; Oberhoffer M; Daebritz S; Schoenberg SO; Reichart B
    J Heart Lung Transplant; 2007 Jan; 26(1):89-92. PubMed ID: 17234523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.